303 related articles for article (PubMed ID: 10862799)
1. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
[TBL] [Abstract][Full Text] [Related]
3. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.
Naot D; Bava U; Matthews B; Callon KE; Gamble GD; Black M; Song S; Pitto RP; Cundy T; Cornish J; Reid IR
J Bone Miner Res; 2007 Feb; 22(2):298-309. PubMed ID: 17129176
[TBL] [Abstract][Full Text] [Related]
5. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
J Bone Miner Res; 2006 Mar; 21(3):446-55. PubMed ID: 16491293
[TBL] [Abstract][Full Text] [Related]
6. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
[TBL] [Abstract][Full Text] [Related]
7. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
9. Studies in Paget's disease and their relevance to oncology.
Roodman GD
Semin Oncol; 2001 Aug; 28(4 Suppl 11):15-21. PubMed ID: 11544571
[TBL] [Abstract][Full Text] [Related]
10. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.
Kurihara N; Reddy SV; Menaa C; Anderson D; Roodman GD
J Clin Invest; 2000 Mar; 105(5):607-14. PubMed ID: 10712432
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
Hoyland JA; Freemont AJ; Sharpe PT
J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
[TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
[TBL] [Abstract][Full Text] [Related]
13. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
[TBL] [Abstract][Full Text] [Related]
15. Cell biology of Paget's disease.
Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
18. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
[TBL] [Abstract][Full Text] [Related]
19. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.
Roccisana JL; Kawanabe N; Kajiya H; Koide M; Roodman GD; Reddy SV
J Biol Chem; 2004 Mar; 279(11):10500-7. PubMed ID: 14699143
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
